Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tauns Laboratories, Inc. ( (JP:197A) ) has issued an update.
Tauns Laboratories has sharply revised down its earnings forecast for the fiscal year ending June 30, 2026, cutting projected net sales by 27.6% to ¥15.0 billion and operating income by 47.5% amid weaker-than-expected infectious disease activity in the latter part of the year. While the influenza season started earlier than usual and COVID-19 infections supported record second-quarter sales, a milder third quarter has led management to expect full-year profits and earnings per share to fall significantly below prior guidance, although its dividend forecast remains unchanged.
The revised outlook still compares unfavorably with the previous fiscal year, when the company generated ¥18.6 billion in net sales and higher profit levels, underscoring the volatility of Tauns’s business as infection waves recede. For investors and healthcare stakeholders, the update highlights the company’s strong leverage to epidemic trends: a surge in demand can quickly lift quarterly results, but any reduction in outbreak scale can materially pressure full-year performance and temper growth expectations.
The most recent analyst rating on (JP:197A) stock is a Hold with a Yen574.00 price target. To see the full list of analyst forecasts on Tauns Laboratories, Inc. stock, see the JP:197A Stock Forecast page.
More about Tauns Laboratories, Inc.
Tauns Laboratories, Inc. is a Japan-based diagnostics company listed on the Tokyo Stock Exchange Standard Market that develops and sells clinical testing kits, with a particular focus on infectious disease diagnostics such as influenza and COVID-19. The company’s revenues are closely tied to seasonal patterns of disease outbreaks, making its earnings sensitive to changes in infection trends and testing demand.
Average Trading Volume: 461,301
Technical Sentiment Signal: Buy
Current Market Cap: Yen56.3B
Find detailed analytics on 197A stock on TipRanks’ Stock Analysis page.